Birth Defects Prevention Month: Medications

Hale said it is important to tell your doctor medications you're taking early in pregnancy because most birth defect occur in the first trimester.

Hale said it is important to tell your doctor medications you're taking early in pregnancy because most birth defect occur in the first trimester.

More than four million babies are born each year in the Untied States. On average, three percent of those births will result in a birth defect ranging from minor to serious.

New mothers often worry about the effects medications can have on unborn children. Through years of research, many medications that cause severe birth defects have been identified and are avoided during pregnancy.

Thomas W. Hale, R.Ph., Ph.D., executive director of the InfantRisk Center, said there are fewer than 30 medications that cause severe birth defects.

“Accutane, alcohol, thalidomide and others can produce quite horrific birth defects,” Hale said. “We know which medications those are and we shy away from them.”

Most birth defects occur in the first trimester, which makes it important for women to be honest with physicians about medications they are taking before trying to conceive. However, physicians have learned that key factors to healthy babies are healthy mothers.

“A healthy woman makes a healthy baby,” Hale said. “Over the years, we’ve decided it’s best to keep moms healthy and treat their syndromes appropriately. As long as mom is healthy, she is going to make a healthy baby and not be so worried about many of these medications.”

Hale used depression as an example. He said depressed mothers have a higher risk of complications during pregnancy and delivery, and doctors now suggest moms treat their depression while pregnant knowing the risk of the medications are less than the risk of untreated depression.

“We get calls when mothers who refuse to tell their doctors what medications they are taking,” Hale said. “It’s important that the physician knows everything they are taking so they can make decisions on whether or not those are safe for the mother and their fetus.”

The InfantRisk Center serves as a resource to pregnant and breastfeeding mothers who have questions about medications. The call center is based solely on evidence-based medicine and research and provides the most current and accurate information possible. The InfantRisk Center also provides information to many health care providers.

Anyone with questions can call the InfantRisk Center from 8 a.m. to 5 p.m., Monday through Friday at (806) 352-2519.

 

Related Stories

TTUHSC School of Nursing to Celebrate New YWCA Location

Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.

A Rite of Passage for Next Generation of Physicians

Students in TTUHSC's School of Medicine Class of 2028 received their first white coat and pledged their commitment to the medical profession at the White Coat Ceremony Friday (July 26) at the Buddy Holly Hall of Performing Arts and Sciences.

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Recent Stories

Research

ASCO GU Symposium Announces New Findings on Tumor Reduction and Survival Outcomes in Advanced Renal Cell Carcinoma

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at TTUHSC and director of the UMC Cancer Center, shared groundbreaking findings from the landmark CLEAR study.

Education

Guest Named Abilene Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Heather Guest, Ph.D., R.N., has been named the Texas Tech University Health Sciences Center (TTUHSC) School of Nursing regional dean in Abilene. TTUHSC School of Nursing Dean Holly Wei, Ph.D., R.N., made the announcement, effective Jan. 1, 2025.

Research

Researcher Develops Method to Measure Blood-Brain Barrier Permeability Accurately

Quentin R. Smith, Ph.D., from the Department of Pharmaceutical Sciences at the TTUHSC Jerry H. Hodge School of Pharmacy, sought to reconcile discrepancies in the field and provide accurate methods for measuring permeability over a very broad range.